Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02262741
Title A Phase I Study to Evaluate the Safety, Tolerability and Efficacy of MEDI4736 With Tremelimumab or Tremelimumab Alone in Head and Neck Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC
Indications

hypopharynx cancer

oral cavity cancer

oropharynx cancer

laryngeal squamous cell carcinoma

head and neck squamous cell carcinoma

Therapies

Tremelimumab

Durvalumab

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.